annual cash & cash equivalents:
$3.05B+$1.91B(+168.94%)Summary
- As of today (June 22, 2025), EW annual cash & cash equivalents is $3.05 billion, with the most recent change of +$1.91 billion (+168.94%) on December 31, 2024.
- During the last 3 years, EW annual cash & cash equivalents has risen by +$2.18 billion (+252.94%).
- EW annual cash & cash equivalents is now at all-time high.
Performance
EW Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$3.14B+$95.40M(+3.13%)Summary
- As of today (June 22, 2025), EW quarterly cash & cash equivalents is $3.14 billion, with the most recent change of +$95.40 million (+3.13%) on March 1, 2025.
- Over the past year, EW quarterly cash & cash equivalents has increased by +$1.92 billion (+156.46%).
- EW quarterly cash & cash equivalents is now -14.57% below its all-time high of $3.68 billion, reached on September 30, 2024.
Performance
EW quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EW Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +168.9% | +156.5% |
| 3 y3 years | +252.9% | +204.7% |
| 5 y5 years | +158.3% | +373.8% |
EW Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +296.0% | -14.6% | +308.4% |
| 5 y | 5-year | at high | +296.0% | -14.6% | +373.8% |
| alltime | all time | at high | >+9999.0% | -14.6% | >+9999.0% |
EW Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $3.14B(+3.1%) |
| Dec 2024 | $3.05B(+168.9%) | $3.05B(-17.2%) |
| Sep 2024 | - | $3.68B(+123.6%) |
| Jun 2024 | - | $1.64B(+34.3%) |
| Mar 2024 | - | $1.22B(+8.2%) |
| Dec 2023 | $1.13B(+47.2%) | $1.13B(-19.7%) |
| Sep 2023 | - | $1.41B(+35.2%) |
| Jun 2023 | - | $1.04B(+19.5%) |
| Mar 2023 | - | $872.50M(+13.5%) |
| Dec 2022 | $769.00M(-10.9%) | $769.00M(-38.4%) |
| Sep 2022 | - | $1.25B(+4.1%) |
| Jun 2022 | - | $1.20B(+16.2%) |
| Mar 2022 | - | $1.03B(+19.5%) |
| Dec 2021 | $862.80M(-27.1%) | $862.80M(-42.7%) |
| Sep 2021 | - | $1.51B(+14.8%) |
| Jun 2021 | - | $1.31B(+11.8%) |
| Mar 2021 | - | $1.17B(-0.8%) |
| Dec 2020 | $1.18B(+0.3%) | $1.18B(+15.5%) |
| Sep 2020 | - | $1.02B(+13.3%) |
| Jun 2020 | - | $903.50M(+36.3%) |
| Mar 2020 | - | $662.90M(-43.8%) |
| Dec 2019 | $1.18B(+65.1%) | $1.18B(-0.6%) |
| Sep 2019 | - | $1.19B(+63.3%) |
| Jun 2019 | - | $726.80M(+2.5%) |
| Mar 2019 | - | $709.20M(-0.7%) |
| Dec 2018 | $714.10M(-12.7%) | $714.10M(-43.4%) |
| Sep 2018 | - | $1.26B(+2.8%) |
| Jun 2018 | - | $1.23B(-0.0%) |
| Mar 2018 | - | $1.23B(+49.9%) |
| Dec 2017 | $818.30M(-12.0%) | $818.30M(+29.8%) |
| Sep 2017 | - | $630.30M(+24.0%) |
| Jun 2017 | - | $508.20M(-38.0%) |
| Mar 2017 | - | $819.30M(-11.9%) |
| Dec 2016 | $930.10M(+29.5%) | $930.10M(+44.2%) |
| Sep 2016 | - | $645.00M(+74.4%) |
| Jun 2016 | - | $369.90M(-26.2%) |
| Mar 2016 | - | $501.40M(-30.2%) |
| Dec 2015 | $718.40M(+9.9%) | $718.40M(+11.2%) |
| Sep 2015 | - | $646.10M(+8.1%) |
| Jun 2015 | - | $597.60M(+30.8%) |
| Mar 2015 | - | $457.00M(-30.1%) |
| Dec 2014 | $653.80M(+55.5%) | $653.80M(+61.8%) |
| Sep 2014 | - | $404.10M(-19.0%) |
| Jun 2014 | - | $498.60M(+68.6%) |
| Mar 2014 | - | $295.70M(-29.7%) |
| Dec 2013 | $420.40M(+35.2%) | $420.40M(-10.7%) |
| Sep 2013 | - | $471.00M(+26.4%) |
| Jun 2013 | - | $372.70M(-7.2%) |
| Mar 2013 | - | $401.50M(+29.1%) |
| Dec 2012 | $310.90M | $310.90M(+1.7%) |
| Sep 2012 | - | $305.80M(+0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $304.30M(+42.7%) |
| Mar 2012 | - | $213.30M(+24.6%) |
| Dec 2011 | $171.20M(-56.8%) | $171.20M(-62.0%) |
| Sep 2011 | - | $451.10M(-3.7%) |
| Jun 2011 | - | $468.20M(+7.9%) |
| Mar 2011 | - | $433.80M(+9.5%) |
| Dec 2010 | $396.10M(+18.6%) | $396.10M(+9.7%) |
| Sep 2010 | - | $361.00M(+12.7%) |
| Jun 2010 | - | $320.30M(-0.3%) |
| Mar 2010 | - | $321.20M(-3.9%) |
| Dec 2009 | $334.10M(+52.8%) | $334.10M(+16.2%) |
| Sep 2009 | - | $287.60M(+57.1%) |
| Jun 2009 | - | $183.10M(+24.8%) |
| Mar 2009 | - | $146.70M(-32.9%) |
| Dec 2008 | $218.70M(+54.2%) | $218.70M(+8.1%) |
| Sep 2008 | - | $202.40M(+7.5%) |
| Jun 2008 | - | $188.20M(+15.5%) |
| Mar 2008 | - | $162.90M(+14.9%) |
| Dec 2007 | $141.80M(-22.4%) | $141.80M(-19.3%) |
| Sep 2007 | - | $175.70M(+6.5%) |
| Jun 2007 | - | $164.90M(-8.5%) |
| Mar 2007 | - | $180.20M(-1.4%) |
| Dec 2006 | $182.80M(+2.4%) | $182.80M(+20.8%) |
| Sep 2006 | - | $151.30M(-9.5%) |
| Jun 2006 | - | $167.10M(-11.6%) |
| Mar 2006 | - | $189.00M(+5.8%) |
| Dec 2005 | $178.60M(+265.2%) | $178.60M(+103.0%) |
| Sep 2005 | - | $88.00M(-8.4%) |
| Jun 2005 | - | $96.10M(+32.4%) |
| Mar 2005 | - | $72.60M(+48.5%) |
| Dec 2004 | $48.90M(-20.0%) | $48.90M(+57.7%) |
| Sep 2004 | - | $31.00M(-22.5%) |
| Jun 2004 | - | $40.00M(+5.5%) |
| Mar 2004 | - | $37.90M(-38.0%) |
| Dec 2003 | $61.10M(+78.7%) | $61.10M(+59.5%) |
| Sep 2003 | - | $38.30M(-24.5%) |
| Jun 2003 | - | $50.70M(+70.1%) |
| Mar 2003 | - | $29.80M(-12.9%) |
| Dec 2002 | $34.20M(-28.3%) | $34.20M(-12.3%) |
| Sep 2002 | - | $39.00M(+9.9%) |
| Jun 2002 | - | $35.50M(+26.8%) |
| Mar 2002 | - | $28.00M(-41.3%) |
| Dec 2001 | $47.70M(+70.4%) | $47.70M(+103.0%) |
| Sep 2001 | - | $23.50M(-61.9%) |
| Jun 2001 | - | $61.60M(+244.1%) |
| Mar 2001 | - | $17.90M(-36.1%) |
| Dec 2000 | $28.00M(>+9900.0%) | $28.00M(+112.1%) |
| Sep 2000 | - | $13.20M(+560.0%) |
| Jun 2000 | - | $2.00M(-66.7%) |
| Mar 2000 | - | $6.00M |
| Dec 1999 | $0.00 | - |
FAQ
- What is Edwards Lifesciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Edwards Lifesciences?
- What is Edwards Lifesciences annual cash & cash equivalents year-on-year change?
- What is Edwards Lifesciences quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly cash & cash equivalents year-on-year change?
What is Edwards Lifesciences annual cash & cash equivalents?
The current annual cash & cash equivalents of EW is $3.05B
What is the all time high annual cash & cash equivalents for Edwards Lifesciences?
Edwards Lifesciences all-time high annual cash & cash equivalents is $3.05B
What is Edwards Lifesciences annual cash & cash equivalents year-on-year change?
Over the past year, EW annual cash & cash equivalents has changed by +$1.91B (+168.94%)
What is Edwards Lifesciences quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of EW is $3.14B
What is the all time high quarterly cash & cash equivalents for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly cash & cash equivalents is $3.68B
What is Edwards Lifesciences quarterly cash & cash equivalents year-on-year change?
Over the past year, EW quarterly cash & cash equivalents has changed by +$1.92B (+156.46%)